Clinical Trial Update: Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type [Phase 2]

View source ↗

Summary

Phase 2 trial comparing etoposide/cisplatin to irinotecan/cisplatin for advanced gastrointestinal neuroendocrine tumors/g3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neuroendocrine Tumor

Drugs mentioned

• etoposide/cisplatin
• irinotecan/cisplatin

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Gastrointestinal Neuroendocrine Tumor | Phase 2 | Status: UNKNOWN